Operating Lease, Right-of-Use Asset of GALECTIN THERAPEUTICS INC from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
GALECTIN THERAPEUTICS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • GALECTIN THERAPEUTICS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $37,000, a 42% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

GALECTIN THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $37,000 +$11,000 +42% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $52,000 +$17,000 +49% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $66,000 +$21,000 +47% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $16,000 -$30,000 -65% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $26,000 -$36,000 -58% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $35,000 -$35,000 -50% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $45,000 -$33,000 -42% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $46,000 -$40,000 -47% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $62,000 -$31,000 -33% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $70,000 -$31,000 -31% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $78,000 -$30,000 -28% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $86,000 +$79,000 +1129% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $93,000 +$75,000 +417% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $101,000 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $108,000 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $7,000 31 Dec 2021 10-K 31 Mar 2022 2021 FY
Q3 2021 $18,000 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.